Skip to Main Content

Advertisement

Skip Nav Destination

Newsroom

Inquiries

Rory Williams
Director of Communications and Marketing
212-327-8603
rory.williams@rockefeller.edu
 

Ben Short
Senior Science Writer
212-327-7053
bshort@rockefeller.edu

Follow us on Twitter: JCB | JEM | JGP | RUP

Embargoed media alerts and PIO Tip Sheets

Sign up for a weekly preview of articles to be published in JCB, JEM, and JGP by contacting Rory Williams. Media alerts are for journalists only. RUP also posts PIO Tip Sheets in EurekAlert every Tuesday to notify authors’ institutions of articles that have been accepted for publication in RUP journals. You may also visit the RUP page on Newswise.

Latest Press Releases

View all press releases...

Recent media coverage

1/14/21 – Researchers link cellular transport pathway to aggressive brain cancer – Journal of Cell Biology
Drug Target ReviewMedicalXpress, MedIndia, The Medical NewseCancerSciencenewsnet, Bioengineer, Scienmag, Infosurhoy
RUP Press Release - Article

1/12/21 – SARS-CoV-2 can infect neurons and damage brain tissue, study indicates – Journal of Experimental Medicine
NIH Director's Blog, The Scientist, MedscapeGEN News, Radio Canada, CosmosNew Atlas, Drug Target Review, The Medical NewsMedicalXpress, Galileu, Medical News Today, Pourquoi DocteurThe Hindu Business LineScienmagBioengineer, Sciencenewsnet, KT News Live, Scimex, La Gazette du Laboratoire, Newsgram, France Culture, MSN, PAP, Sharp Brains, Clinical OMICs
RUP Press Release - Article

12/31/20 – Combined approach could boost breast cancer immunotherapy, study suggests – Journal of Experimental Medicine
Fierce BiotechGEN NewsTechnology Networks, Drug Target ReviewThe Medical News, eCancer`, InfosurhoyScience Daily, Pharmacy TimesBioengineer, UPI, Bionews CentralSciencenewsnet, Agenparl, First World Pharma, Scienmag, AZO Life Sciences, Pourquoi Docteur, Frontline Genomics, Brinkwire, Studyfinds, BioPharma Reporter, Science Codex
RUP Press Release - Article 

12/9/20 – Targeting T cell protein could prevent type 1 diabetes, study suggests – Journal of Experimental Medicine
Fierce Biotech, MedicalXpress, WorldHealth.netThe Medical NewsSciencenewsnet, Infosalus, Infobae, AZO Life Sciences, TekCrispy
RUP Press Release - Article

11/19/20 – Antibody cocktails at low doses could be more effective at treating COVID-19 – Journal of Experimental Medicine
Nature BiotechnologyDrug Target Review, The Medical NewsMedicalXpress, AZO Life SciencesScienmagBioengineer, Sciencenewsnet
RUP Press Release - Article

9/29/20 – Acid reflux drug could help newborn babies recover from brain injury, study suggests – Journal of Experimental Medicine
The Medical News, MedicalXpressSciencenewsnet, MedIndia, Infosalus, Infobae, Medical Dialogues
RUP Press Release - Article

9/14/20 – DNA webs may drive lung pathology in severe COVID-19 – Journal of Experimental Medicine
GEN NewsTechnology NetworksLaboratory Equipment, SciTech Daily, MSN, The Print, The Medical News, Bionewscentral, MedicalXpress, ScienMag, Science Daily, ScienceNewsNet, BeScienced, Bioengineer, DH, Trust My Science, Clinical OMICs, Science Codex, FirstPost, Bio-IT World
RUP Press Release - Article - Article

9/4/2020 – Unconventional T cells in severe COVID-19 patients could predict disease outcome – Journal of Experimental Medicine
La Nouvelle RepubliqueMicrobe PostThe Medical News, ScienceNewsNetMedIndia, Science Daily, MedicalXpressBionewscentral, ScienMag, Bioengineer, Bio-IT World, Science Codex, LabMedica
RUP Press Release - Article

Embargo policy

Rockefeller University Press (RUP) makes embargoed material available to eligible journalists and public information officers for research articles appearing in its three journals: Journal of Cell Biology, Journal of Experimental Medicine, and Journal of General Physiology. Eligible individuals must agree to follow the terms of the RUP embargo policy:

  • Stories or reports on research articles may not be published or placed in the public domain until 10:00 a.m. US Eastern Time on the day of publication. Precise embargo dates and times are clearly marked on all advance material.
  • Public information officers (PIOs) may not distribute embargoed materials in the public domain before the embargo date. However, embargoed materials may be distributed to the media by public information officers. Such releases must be clearly identified as embargoed and must include the embargo date and time. PIOs are responsible for taking all necessary steps to ensure that the embargo is honored by all third parties.
  • All material from RUP journals can be reused without permission for noncommercial purposes, but must be attributed to the appropriate journal and shared expressly under the same restrictions. See our Creative Commons policy for more information.
Close Modal

or Create an Account

Close Modal
Close Modal